Pathoquest
Paris, FR · Founded 2010 · 60 employees on LinkedIn · 2 known investors
Find your way into Pathoquest
PathoQuest develops iDTECT, a platform of Next Generation Sequencing (NGS) assays for biopharmaceutical quality control, offering animal-free viral safety testing and genetic characterization of cell banks and biologics. The company was acquired by Charles River Labs to expand its end-to-end biologics testing portfolio.
Founders & leadership
Pathoquest was founded in 2010 by Marc Eloit.
ME
Marc EloitinFounder and Scientific Advisor
Investors · 2
.jpeg){kind=logo}
Frequently asked questions
- What does Pathoquest do?
- PathoQuest develops iDTECT, a platform of Next Generation Sequencing (NGS) assays for biopharmaceutical quality control, offering animal-free viral safety testing and genetic characterization of cell banks and biologics. The company was acquired by Charles River Labs to expand its end-to-end biologics testing portfolio.
- Who founded Pathoquest?
- Pathoquest was founded by Marc Eloit in 2010.
- Who are Pathoquest's investors?
- Pathoquest's investors include Kurma Partners, Verve Ventures.
- Where is Pathoquest headquartered?
- Pathoquest is headquartered in Paris, FR.